IL17A and respiratory failure: The effects of IL-17A in the respiratory tract are dual-faced: while IL-17A is necessary for successful defense against respiratory pathogens like Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans, it can also prompt severe lung damage and destruction, thereby contributing to lung function decline and, in some disease entities, respiratory failure (summarized in4).